Cargando…
Exploiting a natural conformational switch to engineer an Interleukin-2 superkine
The immunostimulatory cytokine interleukin-2 (IL-2) is a growth factor for a wide range of leukocytes, including T cells and natural killer (NK) cells(1–3). Considerable effort has been invested using IL-2 as a therapeutic agent for a variety of immune disorders ranging from AIDS to cancer. However,...
Autores principales: | Levin, Aron M., Bates, Darren L., Ring, Aaron M., Krieg, Carsten, Lin, Jack T., Su, Leon, Moraga, Ignacio L., Raeber, Miro E., Bowman, Gregory R., Novick, Paul, Pande, Vijay S., Fathman, C. Garrison, Boyman, Onur, Garcia, K. Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338870/ https://www.ncbi.nlm.nih.gov/pubmed/22446627 http://dx.doi.org/10.1038/nature10975 |
Ejemplares similares
-
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines
por: Junttila, Ilkka S., et al.
Publicado: (2012) -
Interleukin-2 superkines by computational design
por: Ren, Junming, et al.
Publicado: (2022) -
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate
por: Merchant, Rosemina, et al.
Publicado: (2022) -
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I(+) tumors
por: Wolf, Natalie K., et al.
Publicado: (2022) -
Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection
por: Adamo, Sarah, et al.
Publicado: (2021)